SDF-1 and neurogenesis in HIV-1 associated dementia

SDF-1 和 HIV-1 相关痴呆的神经发生

• 批准号: 7869501
• 负责人: Jialin Charles Zheng
• 金额: $ 14.45万
• 依托单位: UNIVERSITY OF NEBRASKA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-07-01 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7869501
• 关键词: AIDS Dementia Complex; Acute; Affect; Alzheimer' s Disease; Animals; Apoptosis; Area; Astrocytes; Autopsy; Basal Ganglia; Biological Assay; Brain; CXCR4 Receptors; CXCR4 gene; Cathepsin G; Cell Culture System; Cell Cycle; Cell Differentiation process; Cell Proliferation; Cell Survival; Cell physiology; Cells; Central Nervous System Viral Diseases; Cerebrospinal Fluid; Chemotactic Factors; Chemotaxis; Chronic; Cleaved cell; Coculture Techniques; Confocal Microscopy; Cyclin D1; Data; Dementia; Detection; Development; Disease; Encephalitis; Environment; Enzymes; Event; Figs - dietary; Gelatinase A; Gene Cluster; Generations; Goals; Growth Factor; HIV; HIV encephalitis; HIV-1; Harvest; High Pressure Liquid Chromatography; Hippocampus (Brain); Homeostasis; Human; Human immunodeficiency virus test; Immune; Immunohistochemistry; Impairment; In Situ Hybridization; In Situ Nick-End Labeling; In Vitro; Individual; Infection; Inflammation; Inflammatory; Injection of therapeutic agent; Interleukins; Investigation; Kinetics; Knock-out; Knockout Mice; Label; Leukocyte Elastase; Life; Ligands; Lipopolysaccharides; Matrix Metalloproteinases; Measurement; Mediating; Medical center; Methods; Microglia; Mitogen-Activated Protein Kinases; Modality; Modeling; Modification; Monitor; Mononuclear; Multiple Sclerosis; Mus; Nebraska; Nervous system structure; Neurodegenerative Disorders; Neuroglia; Neuronal Differentiation; Neuronal Injury; Neurons; Neuropathogenesis; Neurovirology; Oligodendroglia; Parkinson Disease; Pathology; Pathway interactions; Patients; Peptides; Phagocytes; Phase; Process; Production; Property; Proteins; RNA; Recombinants; Regulation; Research; Resources; Reverse Transcriptase Polymerase Chain Reaction; Rodent Model; Role; Signal Pathway; Signal Transduction; Site; Small Interfering RNA; Staining method; Stains; Stromal Cell-Derived Factor 1; System; Techniques; Testing; Therapeutic; Thick; Thymidine; Time; Tissues; Transcript; Universities; Western Blotting; Work; Wound Healing; abstracting; astrogliosis; brain tissue; cell motility; chemokine; chemokine receptor; cytokine; deprivation; gliogenesis; immunocytochemistry; in vivo; injured; injury and repair; liquid chromatography mass spectrometry; macrophage; migration; monocyte; mouse model; nerve stem cell; neurogenesis; neurotoxic; novel therapeutics; overexpression; prevent; relating to nervous system; release factor; repaired; research study; response; single photon emission computed tomography; transcription factor; treatment effect

Abstract: Neural progenitor cells (NPC) are present throughout life and replenish neurons and glia (astrocytes and oligodendrocytes) through neurogenesis, a process that requires proper migration, proliferation and differentiation of NPC. Neurogenesis appears to be dysfunctional in neurodegenerative disorders including HIV-1 associated dementia (HAD), Alzheimer's and Parkinson's diseases, where dead or injured neurons are not replaced. HAD is a neurodegenerative disorder where HIV-1-infected and activated brain mononuclear phagocytes (MP; perivascular macrophages and microglia) mediate inflammatory conditions that alter brain homeostasis. We recently demonstrated that HIV-1-infected and activated macrophages inhibit neurogenesis but enhance gliogenesis. We propose this gliogenesis is mediated through brain inflammation attributable to the dysregulation of stromal cell-derived factor 1 (SDF-1). SDF-1 is an endogenous ligand for the chemokine receptor, CXCR4, which is highly expressed on human NPC and mediates NPC migration. Improper SDF-1 and CXCR4 function can affect neural repair by impairing NPC migration. SDF-1 is released in response to glial activation, mediated by inflammatory cytokines from HIV-1-infected and activated MP such as Interleukin one beta (IL-1¿). SDF-1 is elevated in the cerebrospinal fluid of HAD patients. Activated matrix metalloproteinase-2 (MMP-2) is produced by HIV-1 infected and activated MP and cleaves SDF-1 resulting in a neurotoxic fragment. This proposal will examine the role of HIV-1-infected and activated macrophage in brain inflammation and their effects on neurogenesis. We hypothesize HIV-1-infected and immune- activated MP inhibit neuronal differentiation and promote gliogenesis. Specifically, we propose this shift in neurogenesis is dependent upon SDF-1 produced by activated astrocytes. This gliogenesis may be a consequence of modification/degradation of SDF-1 by factors released from HIV-1-infected MP leading to impairment of normal SDF-1/CXCR4 mediated NPC migration, survival, proliferation and differentiation, generating an environment detrimental to CNS repair. Using our human NPC culture system in a severe combined immune deficient (SCID) HIV-1 encephalitis (HIVE) mouse model, this project will mimic HIV-1-infection and immune-activation of brain MP and investigate the effect of CNS inflammation on neurogenesis. Elucidating the mechanisms of SDF-1/CXCR4 influence on neurogenesis may identify new therapeutic strategies for treating HAD and other neurodegenerative disorders. Relevance: Globally, about 40 million people are infected with HIV. 10-20% of these individuals will eventually develop HIV-associated dementia (HAD). This work will elucidate mechanisms through which neurogenesis is affected by HAD, which could identify new therapeutic strategies for treating HAD and other neurodegenerative disorders.

文摘: